Ro-44-3888
Ro 44-3888 is a non-peptidic, selective and reversible glycoprotein IIb/IIIa inhibitor. It is the active metabolite of sibrafiban. It was being investigated as a treatment for heart conditions, including myocardial infarctions. The development of Ro 44-3888 and sibrafiban was discontinued in 1999 following unfavorable Phase III efficacy data.
Identifiers | |
---|---|
PubChem CID | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C18H24N4O5 |
Molar mass | 376.413 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.